8-K Announcements
6Material company update
May 11, 2026·SEC
Material company update
Apr 13, 2026·SEC
Material company update
Mar 3, 2026·SEC
CVRx, Inc.(CVRX)Earnings, Financials & Key Ratios
CVRX•NASDAQ
$5.86
Price updated Jun 27, 2026
AboutCVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Show more
- Revenue$57M+10.4%
- EBITDA-$51M+14.2%
- Net Income-$53M+11.1%
- EPS (Diluted)-2.04+23.0%
- Gross Margin85.33%+1.9%
- EBITDA Margin-89.16%+22.3%
- Operating Margin-90.49%+22.0%
- Net Margin-94.1%+19.5%
- ROE-96.59%-18.4%
CVRX Price & Volume
CVRx, Inc. (CVRX) stock price & volume — 10-year historical chart
Loading chart...
Commercial Scaling Friction Challenges CVRx Financial Sustainability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Decelerating
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Sustained Operating Cash Burn
"CVRx faces a critical inflection point as revenue growth has decelerated to 19.6% in 2026Q1, struggling to convert its 87.2% gross margin into operational profitability. The company's reliance on high SG&A spending, which consistently exceeds $20 million per quarter, continues to erode its equity base, which has fallen to $29.1 million. Investors should monitor the sustainability of the current cash burn, as the company's debt-to-equity ratio has risen to 2.03, signaling increasing financial risk as it attempts to penetrate the heart failure market."
Verdict Logic
the company's cash position has declined to $72.3 million in 2026Q1 from a peak of $105.9 million in 2024Q4, suggesting an unsustainable trajectory of capital erosion.
CVRX Growth Metrics
CVRx, Inc. (CVRX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years56.4%
3 Years36.11%
TTM11.73%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-2.16%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM7.34%
Return on Capital
10 Years-39.34%
5 Years-39.17%
3 Years-46.02%
Last Year-47.88%
CVRX Recent Earnings
CVRx, Inc. (CVRX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 11, 2026Metric
Actual
Est
EPS
$0.50+2.0%
$0.51
Rev
$15M+1.9%
$14M
Q1 2026
Feb 12, 2026Metric
Actual
Est
EPS
$0.46-9.5%
$0.42
Rev
$16M+1.6%
$16M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.49+2.0%
$0.50
Rev
$15M-6.7%
$16M
Q3 2025
Aug 4, 2025Metric
Actual
Est
EPS
$0.57-9.6%
$0.52
Rev
$14M-5.6%
$14M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $0.50vs $0.51+2.0% | $15Mvs $14M+1.9% |
| Q1 2026 | Feb 12, 2026 | $0.46vs $0.42-9.5% | $16Mvs $16M+1.6% |
| Q4 2025 | Nov 5, 2025 | $0.49vs $0.50+2.0% | $15Mvs $16M-6.7% |
| Q3 2025 | Aug 4, 2025 | $0.57vs $0.52-9.6% | $14Mvs $14M-5.6% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for CVRx, Inc. (CVRX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $5.86 | $155.5M | -2.87 | 10.45% | -94.1% | -96.59% | — | |
| $83.43 | $4.58B | -18.75 | 10.74% | 7.47% | 9.13% | — | |
| $15.43 | $1.76B | -12.65 | 8.28% | -25.66% | -50.82% | — | |
| $10.28 | $3.99B | 514.00 | 13.85% | 1.55% | 1.56% | — | |
| $80.98 | $103.97B | 21.71 | 8.43% | 13.2% | 9.78% | — | |
| $93.82 | $163.42B | 25.22 | 5.67% | 13.91% | 12.09% | — |
Compare CVRX vs Peers
CVRx, Inc. (CVRX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CVRX SEC Filings & Documents
CVRx, Inc. (CVRX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when CVRX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CVRX Frequently Asked Questions
CVRx, Inc. (CVRX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is CVRx, Inc.'s revenue?
CVRx, Inc. (CVRX) reported $59.1M in revenue for fiscal year 2025. This represents a 844% increase from $6.3M in 2019.
How fast is CVRx, Inc. growing?
CVRx, Inc. (CVRX) grew revenue by 10.4% over the past year. This is steady growth.
Is CVRX profitable?
CVRx, Inc. (CVRX) reported a net loss of $52.7M for fiscal year 2025.
Dividend & Returns
What is CVRX's return on equity?
CVRx, Inc. (CVRX) has a return on equity (ROE) of -96.6%. Negative ROE indicates the company is unprofitable.
What is CVRx, Inc.'s free cash flow?
CVRx, Inc. (CVRX) had negative free cash flow of $40.2M in fiscal year 2025, likely due to heavy capital investments.